Reduced cannabis use after low-dose naltrexone addition to opioid detoxification.
Publication
, Journal Article
Mannelli, P; Peindl, K; Patkar, AA; Wu, L-T; Pae, C-U; Gorelick, DA
Published in: J Clin Psychopharmacol
August 2010
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Psychopharmacol
DOI
EISSN
1533-712X
Publication Date
August 2010
Volume
30
Issue
4
Start / End Page
476 / 478
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Psychiatry
- Opioid-Related Disorders
- Narcotic Antagonists
- Naltrexone
- Marijuana Abuse
- Logistic Models
- Humans
- Follow-Up Studies
- Dose-Response Relationship, Drug
Citation
APA
Chicago
ICMJE
MLA
NLM
Mannelli, P., Peindl, K., Patkar, A. A., Wu, L.-T., Pae, C.-U., & Gorelick, D. A. (2010). Reduced cannabis use after low-dose naltrexone addition to opioid detoxification. J Clin Psychopharmacol, 30(4), 476–478. https://doi.org/10.1097/JCP.0b013e3181e5c168
Mannelli, Paolo, Kathi Peindl, Ashwin A. Patkar, Li-Tzy Wu, Chi-Un Pae, and David A. Gorelick. “Reduced cannabis use after low-dose naltrexone addition to opioid detoxification.” J Clin Psychopharmacol 30, no. 4 (August 2010): 476–78. https://doi.org/10.1097/JCP.0b013e3181e5c168.
Mannelli P, Peindl K, Patkar AA, Wu L-T, Pae C-U, Gorelick DA. Reduced cannabis use after low-dose naltrexone addition to opioid detoxification. J Clin Psychopharmacol. 2010 Aug;30(4):476–8.
Mannelli, Paolo, et al. “Reduced cannabis use after low-dose naltrexone addition to opioid detoxification.” J Clin Psychopharmacol, vol. 30, no. 4, Aug. 2010, pp. 476–78. Pubmed, doi:10.1097/JCP.0b013e3181e5c168.
Mannelli P, Peindl K, Patkar AA, Wu L-T, Pae C-U, Gorelick DA. Reduced cannabis use after low-dose naltrexone addition to opioid detoxification. J Clin Psychopharmacol. 2010 Aug;30(4):476–478.
Published In
J Clin Psychopharmacol
DOI
EISSN
1533-712X
Publication Date
August 2010
Volume
30
Issue
4
Start / End Page
476 / 478
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Psychiatry
- Opioid-Related Disorders
- Narcotic Antagonists
- Naltrexone
- Marijuana Abuse
- Logistic Models
- Humans
- Follow-Up Studies
- Dose-Response Relationship, Drug